Mateusz Opyrchal, MD
NPI 1316141658 · Hematology & Oncology Physician · Indianapolis, IN
Enrolled with Medicare as Practitioner - Hematology/Oncology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Mateusz Opyrchal, MD is a Hematology & Oncology Physician provider in Indianapolis, IN (NPI 1316141658).
Provider details
- NPI number
- 1316141658
- Entity type
- Individual
- Primary specialty
- Hematology & Oncology PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD
- Sex
- Male
- Sole proprietor
- No
- License
- 2019033210 (MO)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
19 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
2 documented practice locations
- Medicare service volume (vs. specialty peers)25% of score
129 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 100 | $84 |
| Established Patient Office Or Other Outpatient Visit With High Level of Medical Decision Making, If Using Time, 40 Minutes Or More99215 | 17 | $167 |
| New Patient Office Or Other Outpatient Visit With Moderate Level of Medical Decision Making, If Using Time, 45 Minutes Or More99204 | 12 | $154 |
Typical Medicare-allowed amounts for these services range $84–$167 (2024). The Medicare-allowed amount is what Medicare recognizes for a service under fee-for-service — a reference figure for 2024, not a price quote and not what you would be billed. Medicare Part B covers roughly an eighth of all NPIs (65+ skew); services with fewer than 11 beneficiaries are suppressed by CMS. Source: CMS Medicare Physician & Other Practitioners, by Provider & Service.
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 6 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Letrozole | 228 | 76 |
| Anastrozole | 86 | 33 |
| Tamoxifen Citrate | 42 | 16 |
| Dexamethasone | 20 | — |
| Palbociclibbrand: Ibrance | 12 | — |
| Trazodone Hcl | 11 | — |
Medicare Part D only. These counts cover prescriptions paid through Medicare Part D in 2024 — they do notinclude cash-pay, commercial-insurance, Medicaid, or Part B–administered drugs, and badly undercount high cash-pay categories (e.g. GLP-1 weight-loss, testosterone, and ED medications). Any drug with 10 or fewer claims is omitted by CMS, and beneficiary counts under 11 are suppressed — so a missing drug means , never zero. This is a factual claims summary, not an endorsement, not medical advice, and not a consumer report. Source: CMS Medicare Part D Prescribers — by Provider and Drug.
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$893 across 21 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Additional practice locations (1)
- 4921 Parkview PlDiv Im Medical Oncology, Ste 7a, 7b, 7cSaint Louis, MO 63110-1032Phone: (800) 647-2098Fax: (314) 362-3192
Registry dates
- Enumerated
- 2007-06-12
- Last updated
- 2025-03-15
- Certified
- 2025-03-15
Frequently asked questions
- What is Mateusz Opyrchal's NPI number?
- Mateusz Opyrchal's National Provider Identifier (NPI) is 1316141658, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Mateusz Opyrchal's specialty?
- Mateusz Opyrchal is listed in the NPPES registry with a primary specialty of Hematology & Oncology Physician (Allopathic & Osteopathic Physicians).
- Where is Mateusz Opyrchal located?
- Mateusz Opyrchal's practice location on file with NPPES is 1701 N Senate Blvd, Indianapolis, IN 46202-1239.
- What is Mateusz Opyrchal's phone number?
- The practice phone number listed in the NPPES registry for Mateusz Opyrchal is (888) 484-3258.
- Does Mateusz Opyrchal accept Medicare?
- Mateusz Opyrchal is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Mateusz Opyrchal's NPI active?
- Yes — Mateusz Opyrchal's NPI (1316141658) is active in the NPPES registry as of the last update on 2025-03-15.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.